IN2014MN02106A - - Google Patents

Download PDF

Info

Publication number
IN2014MN02106A
IN2014MN02106A IN2106MUN2014A IN2014MN02106A IN 2014MN02106 A IN2014MN02106 A IN 2014MN02106A IN 2106MUN2014 A IN2106MUN2014 A IN 2106MUN2014A IN 2014MN02106 A IN2014MN02106 A IN 2014MN02106A
Authority
IN
India
Prior art keywords
compound
formula
disclosed
preparation
pharmaceutically acceptable
Prior art date
Application number
Other languages
English (en)
Inventor
Fabio E S Souza
Alena Rudolph
Ming Pan
Boris Gorin
Teng Ko Ngooi
Jason A Bexrud
Ricardo Orprecio
Huzaifa Rangwala
Original Assignee
Alphora Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alphora Res Inc filed Critical Alphora Res Inc
Publication of IN2014MN02106A publication Critical patent/IN2014MN02106A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/02Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/04Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
IN2106MUN2014 2012-03-30 2013-03-28 IN2014MN02106A (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261618004P 2012-03-30 2012-03-30
US201261647127P 2012-05-15 2012-05-15
PCT/CA2013/050254 WO2013142999A1 (en) 2012-03-30 2013-03-28 Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein

Publications (1)

Publication Number Publication Date
IN2014MN02106A true IN2014MN02106A (me) 2015-09-11

Family

ID=49258019

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2106MUN2014 IN2014MN02106A (me) 2012-03-30 2013-03-28

Country Status (8)

Country Link
US (2) US9278979B2 (me)
EP (1) EP2831082B1 (me)
JP (1) JP6531911B2 (me)
CN (1) CN104334562A (me)
AU (1) AU2013239290B2 (me)
CA (1) CA2868627C (me)
IN (1) IN2014MN02106A (me)
WO (1) WO2013142999A1 (me)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1771431A1 (en) 2004-06-03 2007-04-11 Eisai Co., Ltd. Intermediates for the preparation of halichondrin b
BRPI0817909B1 (pt) 2007-10-03 2022-06-21 Eisai R&D Management Co., Ltd Métodos de obtenção e de preparação de uma composição diastereomericamente pura, compostos, e método para produzir os referidos compostos
EP2528914B1 (en) 2010-01-26 2014-06-11 Eisai R&D Management Co., Ltd. Furo[3,2-b]pyrane derivatives useful in the synthesis of halichondrin b analogs
US9181152B2 (en) 2011-11-30 2015-11-10 Alphora Research Inc. Process for preparation of (3R)-2,4-di-leaving group-3-methylbut-1-ene
AU2012350420A1 (en) 2011-12-16 2014-07-10 Alphora Research Inc. Process for preparation of 3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl) propanol derivatives and intermediates useful thereof
JP6300030B2 (ja) 2011-12-29 2018-03-28 サンド アクツィエンゲゼルシャフト 2−((2s,3s,4r,5r)−5−((s)−3−アミノ−2−ヒドロキシプロプ−1−イル)−4−メトキシ−3−(フェニルスルホニルメチル)テトラヒドロフラン−2−イル)アセトアルデヒド誘導体およびこれらを調製するためのプロセス
CA2916537C (en) 2013-07-03 2021-07-27 Alphora Research Inc. Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein including intermediates containing -so2-(p-tolyl) groups
CN103483352A (zh) * 2013-10-18 2014-01-01 李友香 抗肿瘤的药用原料药
HUE049387T2 (hu) * 2013-11-04 2020-09-28 Eisai R&D Man Co Ltd A halichondrin B analógjainak szintézisében hasznos makrociklizációs reakciók és köztitermékek
HUE043088T2 (hu) 2013-12-06 2019-08-28 Eisai R&D Man Co Ltd Halikondrin B analógok szintézisében alkalmazható eljárások
TW201617326A (zh) * 2014-03-06 2016-05-16 Alphora研發股份有限公司 (s)-1-((2r,3r,4s,5s)-5-烯丙-3-甲氧-4-(對甲苯磺醯甲基)四氫呋喃-2-基)-3-氨基丙-2-醇之結晶衍生物
US10556910B2 (en) 2014-06-30 2020-02-11 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
CN105713031B (zh) * 2014-12-05 2021-05-07 正大天晴药业集团股份有限公司 一种用于制备艾日布林的中间体及其制备方法
WO2016176560A1 (en) 2015-04-30 2016-11-03 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
EP3292130B1 (en) 2015-05-07 2020-09-30 Eisai R&D Management Co., Ltd. Macrocyclization reactions and intermediates and other fragments useful in the synthesis of halichondrin macrolides
CN108601760A (zh) 2016-02-12 2018-09-28 卫材R&D管理有限公司 艾日布林的合成中的中间体及相关的合成方法
MD3423105T2 (ro) 2016-03-02 2021-10-31 Eisai R&D Man Co Ltd Conjugați anticorp-medicament pe bază de eribulină și metode de utilizare
EP3464297B1 (en) * 2016-05-26 2023-10-25 Dr. Reddy's Laboratories Ltd. Process for preparation of eribulin and intermediates thereof
CN109641917B (zh) 2016-06-30 2022-06-14 卫材R&D管理有限公司 可用于合成软海绵素大环内酯类及其类似物的普林斯反应和中间体
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
JP2020511404A (ja) 2016-11-23 2020-04-16 ドクター レディズ ラボラトリーズ リミテッド エリブリン及びその中間体の調製方法
CN108658956B (zh) * 2017-03-28 2021-02-02 上海时莱生物技术有限公司 艾日布林中间体及其制备方法
HUE060466T2 (hu) 2017-04-05 2023-03-28 Harvard College Makrociklusos vegyület és alkalmazása
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
CN108948064B (zh) * 2017-05-17 2021-02-02 上海时莱生物技术有限公司 一种艾日布林中间体及其制备方法
WO2018217894A1 (en) * 2017-05-24 2018-11-29 Eisai R&D Management Co., Ltd. Fluorine-labelled halichondrin derivatives and related methods of synthesis
IL295588B2 (en) * 2017-07-06 2024-03-01 Harvard College Synthesis of the Lichondrins
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
JP7353281B2 (ja) * 2017-11-15 2023-09-29 プレジデント アンド フェローズ オブ ハーバード カレッジ 大環状化合物およびそれらの使用
SG11202005548WA (en) * 2018-01-03 2020-07-29 Eisai R&D Man Co Ltd Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereof
CN114213429B (zh) * 2021-12-22 2023-06-20 苏州正济药业有限公司 一种甲磺酸艾立布林杂质的制备方法
WO2024153123A1 (zh) * 2023-01-17 2024-07-25 成都百利多特生物药业有限责任公司 一种艾日布林类药物的偶联物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436238A (en) 1992-03-12 1995-07-25 President And Fellows Of Harvard College Halichondrins and related compounds
US5338865A (en) 1992-03-12 1994-08-16 President And Fellows Of Harvard College Synthesis of halichondrin B and norhalichondrin B
CA2166898C (en) 1993-07-09 2004-09-07 Roger Bouillon Novel structural analogues of vitamin d
JP4454151B2 (ja) 1998-06-17 2010-04-21 エーザイ・アール・アンド・ディー・マネジメント株式会社 大環状類似体及びそれらの使用並びに調製方法
US7001982B2 (en) 2003-03-31 2006-02-21 Council Of Scientific And Industrial Research Non-natural C-linked carbo-β-peptides with robust secondary structures
EP1771431A1 (en) 2004-06-03 2007-04-11 Eisai Co., Ltd. Intermediates for the preparation of halichondrin b
US20060045846A1 (en) * 2004-08-30 2006-03-02 Horstmann Thomas E Reagents and methods for labeling terminal olefins
EP2274309B1 (en) * 2008-04-04 2015-07-29 Eisai R&D Management Co., Ltd. Halichondrin b analogs
US9181152B2 (en) 2011-11-30 2015-11-10 Alphora Research Inc. Process for preparation of (3R)-2,4-di-leaving group-3-methylbut-1-ene
AU2012350420A1 (en) 2011-12-16 2014-07-10 Alphora Research Inc. Process for preparation of 3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl) propanol derivatives and intermediates useful thereof
JP6300030B2 (ja) * 2011-12-29 2018-03-28 サンド アクツィエンゲゼルシャフト 2−((2s,3s,4r,5r)−5−((s)−3−アミノ−2−ヒドロキシプロプ−1−イル)−4−メトキシ−3−(フェニルスルホニルメチル)テトラヒドロフラン−2−イル)アセトアルデヒド誘導体およびこれらを調製するためのプロセス
US9650397B2 (en) 2013-05-15 2017-05-16 Alphora Research Inc. 3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives, their preparation and intermediates useful thereof

Also Published As

Publication number Publication date
EP2831082A1 (en) 2015-02-04
EP2831082A4 (en) 2016-01-06
CA2868627C (en) 2021-02-16
JP2015512897A (ja) 2015-04-30
US20160152631A1 (en) 2016-06-02
JP6531911B2 (ja) 2019-06-19
AU2013239290B2 (en) 2017-08-03
WO2013142999A1 (en) 2013-10-03
US9278979B2 (en) 2016-03-08
US20150065733A1 (en) 2015-03-05
CA2868627A1 (en) 2013-10-03
EP2831082B1 (en) 2019-02-20
US9695187B2 (en) 2017-07-04
CN104334562A (zh) 2015-02-04
AU2013239290A1 (en) 2014-10-30

Similar Documents

Publication Publication Date Title
IN2014MN02106A (me)
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
MX2016006336A (es) Compuestos pirazolopirimidina.
GEP20207105B (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors
IN2014MN01521A (me)
IN2014MN02598A (me)
AU2012214029A8 (en) Rorgammat inhibitors
UA110354C2 (uk) Противірусні сполуки
PH12014502040A1 (en) Heterocyclyl compounds
TN2011000400A1 (en) Inhibitors of beta-secretase
NZ729037A (en) Carboxylic acid compound, method for preparation thereof, and use thereof
MY175854A (en) Novel quinolone derivatives
EA201491362A1 (ru) Анестезирующие соединения и способы их применения
IN2014MN02459A (me)
IN2014CN04530A (me)
PH12014501514A1 (en) New azetidine derivatives, pharmaceutical compositions and uses thereof
CR20200286A (es) DERIVADOS DE DIHIDRO-BENZO-OXAZINA Y DIHIDRO-PIRIDO-OXAZINA (Divisional 2014-0294)
IN2015DN01119A (me)
PH12016500885A1 (en) Novel heterocyclic compounds
PH12016500394A1 (en) Polymorphic form of pyrrole derivative and intermediate thereof
MD20160105A2 (ro) 2-Amino-6-metil-4,4a,5,6-tetrahidropirano[3,4-d][1,3]tiazin-8a(8H)-il-1,3-tiazol-4-il amide
IN2012DN02502A (me)
MX364400B (es) Compuestos de tetraciclina.
MX2013008340A (es) Novedosas 4-amino-n-hidroxi-benzamidas para el tratamiento de cancer.
IN2014CN04449A (me)